Professor Andrea Cipriani, Director of the Oxford Health NHS FT CRF said:
'We are delighted to have been awarded this prestigious funding by the NIHR for another five years. The funding will enable us to continue to deliver innovative early phase clinical research. It is crucial to have dedicated space and staff for mental health research. We will work in close collaboration with the University of Oxford, Oxford Brookes University and other NHS Trusts, as well as with our many industry partners to test and develop better treatments for patients.'
This is the only dedicated mental health CRF supported by the NIHR. During the pandemic the CRF adapted to support the delivery of two major vaccine trials.
Dr Nick Broughton, CEO Oxford Health NHS Foundation Trust said:
'It is a great credit to the achievements of the Oxford Health CRF to receive this significant new funding from the NIHR. Research is a key strategic priority for Oxford Health and we're proud to host the CRF and to support its delivery of early translational and experimental medicine research.'